capecitabine has been researched along with aluminum hydroxide, magnesium hydroxide, drug combination in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banken, L; Cassidy, J; Clive, S; Goggin, T; Jodrell, D; Mulligan, T; Reigner, B; Roos, B; Schulz, R; Utoh, M; Weidekamm, E | 1 |
1 trial(s) available for capecitabine and aluminum hydroxide, magnesium hydroxide, drug combination
| Article | Year |
|---|---|
Influence of the antacid Maalox on the pharmacokinetics of capecitabine in cancer patients.
Topics: Administration, Oral; Adult; Aged; Aluminum Hydroxide; Antacids; Antineoplastic Agents; Biotransformation; Capecitabine; Cross-Over Studies; Deoxycytidine; Drug Combinations; Female; Fluorouracil; Half-Life; Humans; Magnesium Hydroxide; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms | 1999 |